High Impact for Whom? A Qualitative Analysis of Organization Concerns About the Transition to High-Impact Prevention Policy.


Journal

Health promotion practice
ISSN: 1524-8399
Titre abrégé: Health Promot Pract
Pays: United States
ID NLM: 100890609

Informations de publication

Date de publication:
09 2023
Historique:
medline: 6 9 2023
pubmed: 10 5 2022
entrez: 9 5 2022
Statut: ppublish

Résumé

HIV represents a significant health burden in the United States. In 2012, the Centers for Disease Control and Prevention (CDC) stopped recommending many once-promoted interventions as part of a shift from one HIV intervention policy, Diffusion of Effective Behavioral Interventions (DEBI), to another, High Impact Prevention (HIP). Twenty-nine staff members from 10 organizations were interviewed to explore how organizations reacted to this shift. Three major themes emerged: (1) Personal experience, community assessment, and epidemiological evidence influenced organizations' perceptions of efficacy and preference for earlier interventions. (2) Organizations were concerned that HIP interventions were not a good fit for their priority populations. (3) Organizations were frustrated with the top-down approach by the CDC prioritizing HIP interventions over earlier interventions. These results indicate that organizations continue to see value in and provide DEBI interventions. In addition, a more participatory process incorporating qualitative evidence and organizations' experiences may be necessary to achieve widespread de-implementation of DEBI interventions.

Identifiants

pubmed: 35533246
doi: 10.1177/15248399221091537
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

932-943

Subventions

Organisme : NIMH NIH HHS
ID : R21 MH115772
Pays : United States
Organisme : NIMH NIH HHS
ID : R34 MH120512
Pays : United States

Auteurs

Miranda J Reid (MJ)

Washington University in St. Louis, St. Louis, MO, USA.

Emmanuel K Tetteh (EK)

Washington University in St. Louis, St. Louis, MO, USA.

Lucy M Ingaiza (LM)

Washington University in St. Louis, St. Louis, MO, USA.

Cory D Bradley (CD)

Washington University in St. Louis, St. Louis, MO, USA.

M Margaret Dolcini (MM)

School of Social and Behavioral Health Sciences, College of Public Health and Human Sciences, Oregon State University, Corvallis, OR, USA.

Virginia R McKay (VR)

Washington University in St. Louis, St. Louis, MO, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH